Subsequently, CABYR-a/b-silenced and control cells were treated with an agonistic DR5 monoclonal antibody (AD5-10), which has been reported to specifically bind to DR5 and induce cancer cell apoptosis [20]. This evidence concerns the gene TNFRSF10B and cancer.